Clinical Trial Boasts 91% Complete Remission Rate in Children with Relapsed Leukemia
(Seattle Children’s) – Seattle Children’s announced today that 20 of 22 patients treated thus far in a clinical trial using genetically reprogrammed T cells to treat relapsed acute lymphoblastic leukemia (ALL) have achieved complete remission, confirmed by highly sensitive tests […]
Clinical Trial Boasts 91% Complete Remission Rate in Children with Relapsed Leukemia Read More »